ARCHIVES

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

This article is from The Cancer Letter archive.

Vol. 21 No. 38 | October 6, 1995

Download PDF Visit The Full Archive

Related Articles

New CIDAC RFP Limits Recompetition To Small Business Firms

January 6, 1984

In The States: Illinois, Virginia approve Legislation Mandating Coverage of Care In Cancer Clinical Trials

June 4, 1999

RFA/PA/Drug Group Announcement Limited

May 6, 1988

Intermittent Androgen Deprivation Therapy Not Equal to Continuous Treatment, Study Finds

April 26, 2013

In Brief: Hayard Of Sloan-Kettering, Leder Of Harvard to Share 1985 Bristol-Myer Award Of $50,000

March 29, 1985

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005